Yahoo
Paris - Delayed Quote EUR

Ramsay Générale de Santé SA (GDS.PA)

8.78 -0.02 (-0.23%)
As of 1:52:04 PM GMT+1. Market Open.
Chart Range Bar
Loading chart for GDS.PA
  • Previous Close 8.80
  • Open 8.80
  • Bid --
  • Ask --
  • Day's Range 8.78 - 8.80
  • 52 Week Range 8.72 - 11.55
  • Volume 84
  • Avg. Volume 854
  • Market Cap (intraday) 969.043M
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.38
  • Earnings Date Oct 6, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Dec 2, 2014
  • 1y Target Est --

Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. It provides preventive care, primary medicine, medicine surgery obstetrics, oncology, medical imaging, medical care and rehabilitation, home hospitalization, mental health care and addiction treatment, geriatrics, tele monitoring and e health services; and operates medical centres, and mental health day care centres. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. The company was founded in 1987 and is headquartered in Saint-Ouen-sur-Seine, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.

www.ramsaygds.fr

40,597

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

GDS.PA
5.39%
CAC 40 (^FCHI)
1.02%

1-Year Return

GDS.PA
2.01%
CAC 40 (^FCHI)
0.53%

3-Year Return

GDS.PA
56.10%
CAC 40 (^FCHI)
14.46%

5-Year Return

GDS.PA
61.15%
CAC 40 (^FCHI)
16.05%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY13
Revenue 470.6M
Earnings --
Profit Margin 0.00%

Q1

FY13

Q2

FY13

Q3

FY13

Q4

FY13

0
100M
200M
300M
400M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.90%

  • Return on Assets (ttm)

    1.84%

  • Return on Equity (ttm)

    -2.27%

  • Revenue (ttm)

    5.38B

  • Net Income Avi to Common (ttm)

    -41.5M

  • Diluted EPS (ttm)

    -0.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    302.2M

  • Total Debt/Equity (mrq)

    348.78%

  • Levered Free Cash Flow (ttm)

    259.35M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: